Ewing sarcoma from molecular biology to the clinic

Abstract excerpt

In Europe, with an incidence of 7.5 cases per million, Ewing sarcoma (ES) is the second most common primary malignant bone tumor in children, adolescents and young adults, after osteosarcoma. Since the 1980s, conventional treatment has been based on the use of neoadjuvant and adjuvant chemotherapeutic agents combined with surgical resection of the tumor when possible. These treatments have increased the patient...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to RNA modifications and cancer
• Share to RNA Research and Splicing
• Share to Sarcoma Diagnosis and Treatment